Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study

W. Kruis, L. Jonaitis, J. Pokrotnieks, G. Acute, T.L. Mikhailova, M. Horynski, M. Batovsky, I. Racz, K. Kull, M. Faszczyk, R. Greinwald, R. Mueller

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberT1124
Pages (from-to)A489
Issue number4, Suppl.1
Publication statusPublished - Apr 2008
Externally publishedYes
EventAnnual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2008) - San Diego, United States
Duration: 17 May 200822 May 2008

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this